PINK
OCPNY

Olympus Corp

Healthcare Equipment & Supplies
Healthcare

Prices are adjusted according to historical splits.

Olympus Corp Stock Price

Vitals

Today's Low:
$16.91
Today's High:
$17.46
Open Price:
$17.46
52W Low:
$16.43
52W High:
$23
Prev. Close:
$17.04
Volume:
57297

Company Statistics

Market Cap.:
$23.02 billion
Book Value:
505.065
Revenue TTM:
$925.86 billion
Operating Margin TTM:
18.81%
Gross Profit TTM:
$571.70 billion
Profit Margin:
12.98%
Return on Assets TTM:
8.15%
Return on Equity TTM:
23.29%

Company Profile

Olympus Corp had its IPO on under the ticker symbol OCPNY.

The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. Olympus Corp has a staff strength of 31,557 employees.

Stock update

Shares of Olympus Corp opened at $17.46 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $16.91 - $17.46, and closed at $17.24.

This is a +1.14% increase from the previous day's closing price.

A total volume of 57,297 shares were traded at the close of the day’s session.

In the last one week, shares of Olympus Corp have increased by +0.73%.

Olympus Corp's Key Ratios

Olympus Corp has a market cap of $23.02 billion, indicating a price to book ratio of 5.3471 and a price to sales ratio of 0.0261.

In the last 12-months Olympus Corp’s revenue was $925.86 billion with a gross profit of $571.70 billion and an EBITDA of $242.74 billion. The EBITDA ratio measures Olympus Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Olympus Corp’s operating margin was 18.81% while its return on assets stood at 8.15% with a return of equity of 23.29%.

In Q4, Olympus Corp’s quarterly earnings growth was a positive 34.3% while revenue growth was a positive 11.8%.

Olympus Corp’s PE and PEG Ratio

Forward PE
20.1613
Trailing PE
23.6842
PEG
0

Its diluted EPS in the last 12-months stands at $0.76 per share while it has a forward price to earnings multiple of 20.1613 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Olympus Corp’s profitability.

Olympus Corp stock is trading at a EV to sales ratio of 0.0277 and a EV to EBITDA ratio of 0.1033. Its price to sales ratio in the trailing 12-months stood at 0.0261.

Olympus Corp stock pays annual dividends of $14 per share, indicating a yield of 0.59% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$1,392.61 billion
Total Liabilities
$355.25 billion
Operating Cash Flow
$0
Capital Expenditure
$19.00 billion
Dividend Payout Ratio
0%

Olympus Corp ended 2024 with $1,392.61 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1,392.61 billion while shareholder equity stood at $604.47 billion.

Olympus Corp ended 2024 with $0 in deferred long-term liabilities, $355.25 billion in other current liabilities, 124643000000.00 in common stock, $372.57 billion in retained earnings and $183.00 billion in goodwill. Its cash balance stood at $175.75 billion and cash and short-term investments were $193.42 billion. The company’s total short-term debt was $53,223,000,000 while long-term debt stood at $299.51 billion.

Olympus Corp’s total current assets stands at $722.54 billion while long-term investments were $0 and short-term investments were $17.67 billion. Its net receivables were $172.76 billion compared to accounts payable of $56.78 billion and inventory worth $170.91 billion.

In 2024, Olympus Corp's operating cash flow was $0 while its capital expenditure stood at $19.00 billion.

Comparatively, Olympus Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$17.24
52-Week High
$23
52-Week Low
$16.43
Analyst Target Price
$

Olympus Corp stock is currently trading at $17.24 per share. It touched a 52-week high of $23 and a 52-week low of $23. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $17.68 and 200-day moving average was $19.85 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 3.6% are held by institutions.

Frequently Asked Questions About Olympus Corp

The stock symbol (also called stock or share ticker) of Olympus Corp is OCPNY

The IPO of Olympus Corp took place on

Similar Industry Stocks (Healthcare Equipment & Supplies)

Last Price
Chg
Chg%
$23.87
-2.2
-8.44%
$767.35
-40.35
-5%
$14.53
-0.65
-4.28%
$3.93
0.01
+0.26%
Nexgel Inc (NXGL)
$2.32
0.06
+2.65%
$1.04
-0.03
-2.8%
$0.23
-0.02
-6.4%
$26.59
0.47
+1.8%
$38.95
-0.65
-1.64%
$24.85
-0.46
-1.82%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy system, surgical microscopes, endoscope reprocessors, operating rooms, repair and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Address

Shinjuku Monolith, Tokyo, Japan, 163-0914